-The Hindu Apart from vaccination, this has to involve efficient vector control and proper case management The advent of a new tetravalent vaccine against the dengue virus has thrown new light into the evidence-based management of dengue. An article recently published in the New England Journal of Medicine revealed that this vaccine confers about 80% protection to children vaccinated between 4 and 16 years of age without any major side effects. It...

-The Hindu Business Line How the Indian State metamorphosed from protector of the poor to facilitator of the private health industry If there is correlation between two incidents of the Central Government announcing cuts in the health budget and dengue patients being refused treatment in Delhi’s private hospitals, it is rarely discussed in the ongoing media debate on the subject. A new collection of researched essays edited by public health scholar Imrana...

The latest WHO report entitled World Health Statistics 2014 delineates the performance made on the health front by India vis-à-vis other nations between 1990 and 2012. It also presents the challenges that the new government at the Centre should try to resolve. In India, life expectancy at birth (both sexes, in years) has increased from 58 in 1990 to 66 in 2012. While life expectancy at birth for men rose from 57...

-The Indian Express In Gorakhpur, small successes in understanding - and conquering - the killer disease of children are undercut by a wily virus and administrative bottlenecks Gorakhpur: On August 18, five-year-old Vishal spent the evening playing with friends in Vanjhai village in Gorakhpur district's Bhathat block. He came home irritable, with a slight fever. His mother and grandmother gave him a little milk and sent him to bed. They were not...

India’s new vaccination policy stresses increased domestic research and surveillance on local diseases; but has drawn criticism for endorsing new vaccines in the national immunisation programme without ascertaining need. The April 2011 policy, made public by India’s ministry of health and family welfare in August, provides guidelines for vaccine research and development; strengthening the evidence base for new vaccine introduction and regulation and patent issues. It highlights lack of indigenous baseline surveillance...